An2 Therapeutics shares owned by UBS Group
Historical chart of UBS Group investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $72k | 57k | 1.27 |
| 2025-06-30 | $66k | 62k | 1.06 |
| 2025-03-31 | $144k | 106k | 1.36 |
| 2024-12-31 | $235k | 170k | 1.38 |
| 2024-06-30 | $38k | 18k | 2.15 |
| 2024-03-31 | $64k | 20k | 3.25 |
| 2023-09-30 | $660k | 41k | 16.09 |
| 2023-06-30 | $422k | 50k | 8.50 |
| 2023-03-31 | $516k | 52k | 9.87 |
| 2022-12-31 | $490k | 52k | 9.53 |
| 2022-09-30 | $506k | 29k | 17.38 |
| 2022-06-30 | $479k | 48k | 9.90 |
| 2022-03-31 | $17k | 1.2k | 14.36 |